Veradermics
MANE | NYSE
$139.69
-$4.16 (-2.89%)
At close: Oct 30, 2026, 4:00 PM ET
$139.01
-$0.68 (-0.49%)
After-hours:
Oct 30, 2026, 7:30 PM ET
Market Data
Market Cap $5.84B
Enterprise Value $5.02B
Beta 1.23
Average Volume 785.93K
Shares Outstanding (Diluted) 40.44M
Shares Change YoY -79.92%
Institutional Ownership 84.36%
Exchange NYSE
ISIN US9229671048
Price Performance
Price Change 1M 15.2%
Price Change 3M 33.0%
Price Change 6M 38.3%
Price Change YTD N/A
Price Change 1Y N/A
Price Change 3Y N/A
Price Change 5Y N/A
1M CAGR (ann.) 30.9%
1Y CAGR (ann.) N/A
5Y CAGR (ann.) N/A
All-Time CAGR 494.2%
Valuation
PE Ratio -65.28
Forward PE N/A
PEG Ratio 0.71
Forward PEG 0.86
PS Ratio N/A
Forward PS 561.80
PB Ratio 7.17
P/FCF Ratio -74.51
P/Adj. FCF Ratio -66.16
P/OCF Ratio -72.01
EV/Sales N/A
EV/EBIT -51.58
EV/EBITDA -51.58
EV/FCF -64.05
Earnings Yield -1.5%
FCF Yield -1.3%
Adj. FCF Yield -1.5%
Financial Health
Net Cash $819.89M
Total Debt $428K
Cash & Short-Term Investments $819.89M
Total Assets $825.74M
Current Ratio 70.53
Quick Ratio 70.53
Debt / Equity Ratio 0.00
Debt / EBITDA -0.00
Debt / FCF -0.01
OCF / Debt -182.94
Interest Coverage -193.18
Altman Z-Score 289.37
Piotroski F-Score 3
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -12.6%
Returns
Return on Assets -11.2%
Return on Equity -37.5%
Return on Invested Capital -12.6%
Return on Capital Employed -12.6%
Return on Tangible Assets -11.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 6
EPS Growth Next 3Y 28.8%
Revenue Growth Next 3Y N/A
Earnings Date Nov 10, 2026
EPS Estimate (next Q) -$0.59
EPS Growth Est (next Q) -63.7%
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $174.00
Price Target Upside 24.6%
Cash Flow
Operating Cash Flow $-78.3M
Free Cash Flow $-78.33M
Adj. Free Cash Flow $-88.21M
FCF Per Share -$1.94
OCF Per Share -$1.94
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $0
Operating Income $-102.77M
EBITDA $-97.26M
Net Income $-92.68M
EPS (Diluted) -$2.14
Revenue / Employee N/A
Profit / Employee $-2.5M
Employees 37
Add to Watchlist
Select watchlists to add or remove MANE